🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/08/1994 | 15,27 | 15,39 | 15,15 | 15,39 | +0,78% | 1,56% | 4.151.547 |
| 11/08/1994 | 15,33 | 15,45 | 15,15 | 15,27 | -0,77% | 1,95% | 6.994.142 |
| 10/08/1994 | 14,79 | 15,39 | 14,73 | 15,39 | +4,45% | 4,44% | 11.432.842 |
| 09/08/1994 | 14,55 | 14,79 | 14,55 | 14,73 | +1,23% | 1,64% | 6.060.374 |
| 08/08/1994 | 14,37 | 14,67 | 14,31 | 14,55 | +2,09% | 2,49% | 5.155.112 |
| 05/08/1994 | 14,25 | 14,31 | 14,19 | 14,25 | -0,42% | 0,84% | 3.665.485 |
| 04/08/1994 | 14,37 | 14,37 | 14,19 | 14,31 | +0,42% | 1,24% | 5.282.339 |
| 03/08/1994 | 14,31 | 14,43 | 14,19 | 14,25 | -1,24% | 1,67% | 5.725.434 |
| 02/08/1994 | 14,13 | 14,43 | 13,96 | 14,43 | +2,11% | 3,38% | 5.150.920 |
| 01/08/1994 | 14,07 | 14,19 | 14,01 | 14,13 | +0,00% | 1,27% | 4.726.690 |
| 29/07/1994 | 14,19 | 14,25 | 14,07 | 14,13 | -0,42% | 1,26% | 3.444.776 |
| 28/07/1994 | 14,07 | 14,19 | 14,01 | 14,19 | +0,42% | 1,27% | 2.705.726 |
| 27/07/1994 | 14,19 | 14,19 | 14,01 | 14,13 | -0,42% | 1,26% | 2.446.242 |
| 26/07/1994 | 14,25 | 14,25 | 14,13 | 14,19 | -0,83% | 0,84% | 3.312.728 |
| 25/07/1994 | 14,13 | 14,37 | 14,07 | 14,31 | +1,27% | 2,11% | 5.500.323 |
| 22/07/1994 | 14,13 | 14,19 | 14,07 | 14,13 | +0,42% | 0,84% | 2.967.307 |
| 21/07/1994 | 13,96 | 14,13 | 13,84 | 14,07 | +0,43% | 2,14% | 3.828.554 |
| 20/07/1994 | 14,07 | 14,13 | 13,96 | 14,01 | -0,84% | 1,27% | 3.055.968 |
| 19/07/1994 | 14,19 | 14,25 | 14,13 | 14,13 | -0,42% | 0,84% | 2.594.010 |
| 18/07/1994 | 14,13 | 14,25 | 14,01 | 14,19 | +0,85% | 1,69% | 3.040.458 |
| 15/07/1994 | 14,01 | 14,19 | 13,96 | 14,07 | -0,42% | 1,70% | 7.049.058 |
| 14/07/1994 | 13,96 | 14,19 | 13,90 | 14,13 | +1,28% | 2,14% | 4.198.078 |
| 13/07/1994 | 13,96 | 14,01 | 13,90 | 13,96 | +0,43% | 0,85% | 2.808.221 |
| 12/07/1994 | 14,01 | 14,01 | 13,84 | 13,90 | +0,00% | 1,28% | 4.067.288 |
| 11/07/1994 | 14,19 | 14,25 | 13,90 | 13,90 | -1,27% | 2,52% | 4.016.774 |
| 08/07/1994 | 14,19 | 14,25 | 14,01 | 14,07 | -1,26% | 1,68% | 3.993.090 |
| 07/07/1994 | 14,37 | 14,37 | 14,19 | 14,25 | -0,42% | 1,24% | 2.461.542 |
| 06/07/1994 | 14,19 | 14,37 | 14,19 | 14,31 | +0,00% | 1,26% | 2.181.098 |
| 05/07/1994 | 14,13 | 14,37 | 14,07 | 14,31 | +0,42% | 2,11% | 4.044.232 |
| 01/07/1994 | 14,25 | 14,49 | 14,19 | 14,25 | +0,42% | 2,09% | 3.784.538 |